Adaptyv Biosystems utilizes AI to engineer new proteins for diverse applications in medicine, manufacturing, computation, and power generation, enhancing the protein design and testing process.
Employees
12
Revenue
$2.6M
Company Stage
Pre-Seed
YC Batch
S21
Product Features & Capabilities
AI-driven protein design, high-quality experimental data generation for designed proteins, cell-free synthetic biology for protein synthesis, automated workcells for profiling protein functions, integration of AI in the protein engineering cycle.
How much Adaptyv Biosystems raised
1 - $108K
July 1, 2021
Lead Investor: Foundation for Innovation and Technology (FIT)